Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

266.90
-7.6900-2.80%
Post-market: 264.25-2.6500-0.99%16:05 EST
Volume:349.58K
Turnover:93.34M
Market Cap:7.74B
PE:39.02
High:275.00
Open:274.59
Low:262.33
Close:274.59
52wk High:298.30
52wk Low:122.80
Shares:29.00M
Float Shares:22.98M
Volume Ratio:0.69
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.84
EPS(LYR):6.84
ROE:18.91%
ROA:8.44%
PB:6.35
PE(LYR):39.02

Loading ...

Company Profile

Company Name:
Krystal Biotech Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
295
Office Location:
2100 Wharton Street,Suite 701,Pittsburgh,Pennsylvania,United States
Zip Code:
15203
Fax:
- -
Introduction:
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Directors

Name
Position
Krish S. Krishnan
Chairman,President and Chief Executive Officer
Suma M. Krishnan
Director,Founder and President, R&D
Catherine Mazzacco
Director
Christopher Mason
Director
Daniel S. Janney
Director
Dino A. Rossi
Director
E. Rand Sutherland
Director
Julian S. Gangolli
Director

Shareholders

Name
Position
Krish S. Krishnan
Chairman,President and Chief Executive Officer
Kathryn A. Romano
Chief Accounting Officer
Suma M. Krishnan
Director,Founder and President, R&D